New York State Common Retirement Fund Apellis Pharmaceuticals, Inc. Transaction History

New York State Common Retirement Fund

  • $74.9 Billion
  • Q3 2025

A detailed history of New York State Common Retirement Fund transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 48,837 shares of APLS stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,837
Previous 58,879 17.06%
Holding current value
$1.01 Million
Previous $1.02 Million 8.44%
% of portfolio
0.0%
Previous 0.0%

Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025
SELL
$17.42 - $28.65 $174,931 - $287,703
-10,042 Reduced 17.06%
48,837 $1.11 Million
Q2 2025

Oct 08, 2025
BUY
$16.36 - $23.0 $164,287 - $230,966
10,042 Added 20.56%
58,879 $1.02 Million
Q2 2025

Aug 13, 2025
BUY
$16.36 - $23.0 $164,287 - $230,966
10,042 Added 20.56%
58,879 $1.02 Million
Q4 2024

Oct 08, 2025
SELL
$26.18 - $35.42 $8.58 Million - $11.6 Million
-327,776 Reduced 87.03%
48,837 $1.56 Million
Q4 2024

Jan 31, 2025
SELL
$26.18 - $35.42 $8.58 Million - $11.6 Million
-327,776 Reduced 87.03%
48,837 $1.56 Million
Q3 2024

Oct 08, 2025
BUY
$28.84 - $41.15 $9.16 Million - $13.1 Million
317,734 Added 539.64%
376,613 $10.9 Million
Q3 2024

Oct 28, 2024
SELL
$28.84 - $41.15 $1.57 Million - $2.24 Million
-54,500 Reduced 12.64%
376,613 $10.9 Million
Q2 2024

Oct 08, 2025
BUY
$38.07 - $59.71 $14.2 Million - $22.2 Million
372,234 Added 632.2%
431,113 $16.5 Million
Q2 2024

Jul 31, 2024
BUY
$38.07 - $59.71 $4 Million - $6.28 Million
105,187 Added 32.27%
431,113 $16.5 Million
Q1 2024

Oct 08, 2025
BUY
$55.39 - $72.47 $14.8 Million - $19.4 Million
267,047 Added 453.55%
325,926 $19.2 Million
Q1 2024

May 07, 2024
SELL
$55.39 - $72.47 $807,641 - $1.06 Million
-14,581 Reduced 4.28%
325,926 $19.2 Million
Q4 2023

Oct 08, 2025
BUY
$37.14 - $64.82 $10.5 Million - $18.3 Million
281,628 Added 478.32%
340,507 $20.4 Million
Q4 2023

Feb 01, 2024
SELL
$37.14 - $64.82 $2.32 Million - $4.05 Million
-62,437 Reduced 15.5%
340,507 $20.4 Million
Q3 2023

Oct 08, 2025
BUY
$23.65 - $89.22 $8.14 Million - $30.7 Million
344,065 Added 584.36%
402,944 $15.3 Million
Q3 2023

Nov 07, 2023
BUY
$23.65 - $89.22 $2.41 Million - $9.1 Million
101,949 Added 33.87%
402,944 $15.3 Million
Q2 2023

Oct 08, 2025
BUY
$76.68 - $93.31 $18.6 Million - $22.6 Million
242,116 Added 411.21%
300,995 $27.4 Million
Q2 2023

Aug 07, 2023
BUY
$76.68 - $93.31 $4.44 Million - $5.4 Million
57,875 Added 23.81%
300,995 $27.4 Million
Q1 2023

Oct 08, 2025
BUY
$46.59 - $66.96 $6.46 Million - $9.29 Million
138,700 Added 132.83%
243,120 $16 Million
Q1 2023

May 02, 2023
BUY
$46.59 - $66.96 $6.46 Million - $9.29 Million
138,700 Added 132.83%
243,120 $16 Million
Q4 2022

Oct 08, 2025
BUY
$43.24 - $61.04 $1.97 Million - $2.78 Million
45,541 Added 77.35%
104,420 $5.4 Million
Q4 2022

Jan 30, 2023
SELL
$43.24 - $61.04 $1.97 Million - $2.78 Million
-45,534 Reduced 30.37%
104,420 $5.4 Million
Q3 2022

Nov 08, 2022
BUY
$44.76 - $69.66 $2.63 Million - $4.09 Million
58,648 Added 64.23%
149,954 $10.2 Million
Q2 2022

Aug 04, 2022
BUY
$35.07 - $59.21 $477,478 - $806,144
13,615 Added 17.52%
91,306 $4.13 Million
Q1 2022

May 05, 2022
BUY
$35.46 - $54.12 $421,158 - $642,783
11,877 Added 18.05%
77,691 $3.95 Million
Q4 2021

Feb 02, 2022
BUY
$30.74 - $49.16 $578,219 - $924,699
18,810 Added 40.02%
65,814 $3.11 Million
Q3 2021

Nov 02, 2021
SELL
$31.4 - $69.84 $651,895 - $1.45 Million
-20,761 Reduced 30.64%
47,004 $1.55 Million
Q2 2021

Aug 02, 2021
BUY
$40.9 - $64.9 $522,088 - $828,448
12,765 Added 23.21%
67,765 $4.28 Million
Q1 2021

May 11, 2021
SELL
$40.8 - $57.39 $313,548 - $441,042
-7,685 Reduced 12.26%
55,000 $2.36 Million
Q4 2020

Feb 08, 2021
BUY
$30.79 - $57.2 $236,621 - $439,582
7,685 Added 13.97%
62,685 $3.59 Million
Q2 2020

Aug 07, 2020
BUY
$24.8 - $38.49 $106,640 - $165,507
4,300 Added 8.48%
55,000 $1.8 Million
Q1 2020

May 06, 2020
BUY
$17.91 - $44.33 $130,743 - $323,609
7,300 Added 16.82%
50,700 $1.36 Million
Q4 2019

Feb 05, 2020
SELL
$22.1 - $30.8 $143,650 - $200,200
-6,500 Reduced 13.03%
43,400 $1.33 Million
Q3 2019

Nov 07, 2019
BUY
$24.09 - $32.18 $9,636 - $12,872
400 Added 0.81%
49,900 $1.2 Million
Q2 2019

Aug 09, 2019
BUY
$18.0 - $25.34 $277,200 - $390,236
15,400 Added 45.16%
49,500 $1.25 Million
Q4 2018

Feb 08, 2019
SELL
$11.47 - $18.71 $69,967 - $114,131
-6,100 Reduced 15.17%
34,100 $450,000
Q2 2018

Aug 10, 2018
BUY
$19.63 - $30.0 $571,233 - $873,000
29,100 Added 262.16%
40,200 $884,000
Q1 2018

May 10, 2018
BUY
$14.01 - $26.02 $155,511 - $288,822
11,100 New
11,100 $245,000

Others Institutions Holding APLS

# of Institutions
302
Shares Held
134M
Call Options Held
2.97M
Put Options Held
623K
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $2.27B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email